NCI Phase II Small Business Technology Transfer Renewal Awards for Cancer Diagnosis, Prevention, and Treatment (STTR [R42])
The summary for the NCI Phase II Small Business Technology Transfer Renewal Awards for Cancer Diagnosis, Prevention, and Treatment (STTR [R42]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NCI Phase II Small Business Technology Transfer Renewal Awards for Cancer Diagnosis, Prevention, and Treatment (STTR [R42]): This funding opportunity announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose additional funding for the competing renewal (formerly competing continuation) of previously funded Phase II STTR grants to continue the process of developing products for commercialization that ultimately require approval of a Federal regulatory agency and clinical evaluation up to "proof-of-principle" demonstration, generally only through a Phase II clinical trial. Products for potential development include, but are not limited to: drugs, vaccines, radioligands, biomarkers, medical implants or devices, imaging protocols proposed for clinical use, new software for instrument performance, and diagnostic or predictive assays applicable for cancer diagnosis, prevention, and treatment. Current Phase II STTR grantees that have developed promising anticancer agents or biologics, new diagnostic or treatment devices, or biological assays for diagnosis or treatment, etc., are welcome to apply.
|Federal Grant Title:||NCI Phase II Small Business Technology Transfer Renewal Awards for Cancer Diagnosis, Prevention, and Treatment (STTR [R42])|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-06-052|
|Type of Funding:||Grant|
|CFDA Descriptions:||Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple dates, see announcement.|
|Posted Date:||Nov 03, 2005|
|Creation Date:||Nov 03, 2005|
|Archive Date:||No date given|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.395 -- Cancer Treatment Research|
- Applicants Eligible for this Grant
- Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award for both Phase I and Phase II awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's (SBA) Government Contracting Area Office or Office of Size Standards.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...